儿童期复杂注意缺陷多动障碍的评估与治疗

陈立

doi:10.11852/zgetbjzz2023-0845

PDF(501 KB)

中国儿童保健杂志 ›› 2023, Vol. 31 ›› Issue (9) : 935-938. DOI: 10.11852/zgetbjzz2023-0845

专家笔谈

儿童期复杂注意缺陷多动障碍的评估与治疗

陈立

作者信息 +

Evaluation and treatment of complex attention deficit hyperactivity disorder in childhood

CHEN Li

Author information +

文章历史 +

摘要

注意缺陷多动障碍(ADHD)是儿童期最常见的神经发育障碍之一。儿童复杂ADHD在ADHD患者中相对特殊,出现症状的年龄不典型,或存在复杂的共存情况,临床症状与功能损害更重,需要综合性跨专业评估与治疗,并开展长期规范随访和慢病管理。

Abstract

Attention deficit hyperactivity disorder(ADHD) is one of the most common neurodevelopmental disorders in childhood. Complex ADHD in children is relatively unique. These cases differ from typical ADHD cases in various ways, such as the atypical age at which symptoms appear or the presence of complex coexisting conditions. Additionally, the symptoms and functional impairment experienced by children with complex ADHD tend to be more severe.Therefore, these children require comprehensive interdisciplinary evaluation and treatment, as well as long-term standardized follow-up and chronic disease management.

导出引用

陈立. 儿童期复杂注意缺陷多动障碍的评估与治疗[J]. 中国儿童保健杂志. 2023, 31(9): 935-938 https://doi.org/10.11852/zgetbjzz2023-0845

CHEN Li. Evaluation and treatment of complex attention deficit hyperactivity disorder in childhood[J]. Chinese Journal of Child Health Care. 2023, 31(9): 935-938 https://doi.org/10.11852/zgetbjzz2023-0845

中图分类号： R749.94

参考文献

[1] American Academy of Pediatrics, Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents[J]. Pediatrics, 2019, 144(4). pii:e20192528.
[2] Schiweck C, Arteaga-Henriquez G, Aichholzer M, et al. Comorbidity of ADHD and adult bipolar disorder:A systematic review and meta-analysis[J].Neurosci Biobehav Rev, 2021, 124:100-123.
[3] 中华医学会儿科学分会发育行为学组.ADHD早期识别、规范诊断和治疗的儿科临床实践专家共识[J].中华儿科杂志, 2020, 58 (3):188-193.
The Subspecialty Group of Developmental and Behavioral Pediatrics, the Society of Pediatrics, Chinese Medical Association. Consensus on pediatric clinical practice of early identification, standardized diagnosis and treatment of attention deficit hyperactivity disorder[J]. Chin J Pediatr,2020, 58 (3):188-193. (in Chinese)
[4] Barbaresi WJ, Campbell L, Diekroger EA, et al. Society for developmental and behavioral pediatrics clinical practice guideline for the assessment and treatment of children and adolescents with complex attention- deficit/hyperactivity disorder[J]. J Dev Behav Pediatr, 2020, 42(Suppl 2):35-57.
[5] 金星明,李廷玉,陈立,等. 美国发育行为儿科学会儿童及青少年复杂注意缺陷多动障碍评估和治疗的临床实践指南解读[J].中华儿科杂志, 2021, 59(11):912-915.
Jin XM, Li TY, Chen L, et al. Interpretation of American Society for Developmental and Behavioral Pediatrics clinical practice guideline for the assessment and treatment of children and adolescents with complex attention-deficit/hyperactivity disorder[J]. Chin J Pediatr, 2021, 59(11):912-915. (in Chinese)
[6] Reiff FM, Dupaul GJ, Wolraich ML, et al. ADHD:Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.[J]. Pediatrics, 2011, 128(5):1007-1022.
[7] Koolwijk I, Stein DS, Chan E, et al. "Complex" attention-deficit disorder, more norm than exception? Diagnoses and comorbidities in a developmental clinic[J]. J Dev Behav Pediatr, 2014, 35(9):591-597.
[8] Hirota T, King BH. Autism spectrum disorder:A review[J]. JAMA, 2023, 329(2):157-168.
[9] Nickels KC, Katusic SK, Colligan RC, et al. Stimulant medication treatment of target behaviors in children with autism:A population-based study[J]. J Dev Behav Pediatr, 2008, 29(2):75-81.
[10] Antshel KM, Russo N. Autism spectrum disorders and ADHD:Overlapping phenomenology, diagnostic issues, and treatment considerations[J]. Curr Psychiatry Rep,2019 ,21(5):34.
[11] Koyuncu A, Ayan T, Guliyev EI, et al. ADHD and anxiety disorder comorbidity in children and adults:Diagnostic and therapeutic challenges[J]. Curr Psychiatry Rep, 2022, 24(2):129-140.
[12] Powell V, Agha SS, Jones RB, et al. ADHD in adults with recurrent depression[J]. J Affect Disord, 2021, 295:1153-1160.
[13] Sáenz AA, Villemonteix T, Massat I. Structural and functional neuroimaging in attention-deficit/hyperactivity disorder[J]. Dev Med Child Neurol, 2019, 61(4):399-405.
[14] Bridgemohan C, Bauer NS, Nielsen BA, et al. A workforce survey on developmental-behavioral pediatrics[J]. Pediatrics, 2018, 141(3):e20172164.
[15] Yoshimasu K, Barbaresi WJ, Colligan RC, et al. Gender, attention-deficit/hyperactivity disorder, and reading disability in a population-based birth cohort.[J]. Pediatrics, 2010, 126(4):e788-e795.
[16] Yoshimasu K, Barbaresi WJ, Colligan RC, et al. Written-language disorder among children with and without ADHD in a population based birth cohort[J]. Pediatrics, 2011, 128(3):e605-e612.
[17] Esbensen AJ, Epstein JN, Vincent L, et al. Comparison of attention deficit hyperactivity disorder in typically developing children and children with down syndrome[J]. J Dev Behav Pediatr, 2022, 43(1):1-8.
[18] Russell AE, Ford T, Williams R, et al. The association between socioeconomic disadvantage and attention-deficit/hyperactivity disorders (ADHD):A systematic review[J]. Child Psychiatry and Human Development, 2015, 47(3):1-19.
[19] Powell N, Lochman J, Boxmeyer C, et al. The coping power program for aggressive behavior in children[M]// Weisz JR, Kazdin AE. Evidence-based psychotherapies for children and adolescents. 3rd ed. New York, NY:The Guildford Press, 2017:159-176.
[20] Bikic A, Reichow B, McCauley SA, et al. Meta-analysis of organizational skill interventions for children and adolescents with attention-deficit/hyperactivity disorders[J]. Clin Psychol Rev, 2016, 52(1):108-123.
[21] Evans SW, Owens JS, Wymbs BT, et al. Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder[J]. J Clin Child Adolesc Psychol, 2014, 43(4):527-551.
[22] Froehlich TE.Comparison of medication treatments for preschool children with ADHD:A first step toward addressing a critical gap[J]. JAMA, 2021, 325(20):2049-2050.
[23] Elsayed NA, Yamamoto KM, Froehlich TE. Genetic influence on efficacy of pharmacotherapy for pediatric attention-deficit/hyperactivity disorder:Overview and current status of research[J]. CNS Drugs, 2020, 34(4):389-414.
[24] Fiks AG, Mayre S, Debartolo E, et al. Parental preferences and goals regarding ADHD treatment.[J] Pediatrics, 2013, 132(4):692-702.
[25] Fiks AG, Mayrs S, Hughes CC, et al. Development of an instrument to measure parents' preferences and goals for the treatment of attention deficit-hyperactivity disorder[J]. Acad Pediatr, 2012, 12(5):445-455.
[26] Kamimura-Nishimura KI, Brinkman WB, Epstein JN, et al. Predictors of stimulant medication continuity in children with attention-deficit/hyperactivity disorder[J]. J Dev Behav Pediatr, 2022, 43(6):311-319.